HomeCompareHTGM vs JEPQ

HTGM vs JEPQ: Dividend Comparison 2026

HTGM yields 416.67% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HTGM wins by $15446.81M in total portfolio value
10 years
HTGM
HTGM
● Live price
416.67%
Share price
$0.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15446.85M
Annual income
$10,492,957,272.45
Full HTGM calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — HTGM vs JEPQ

📍 HTGM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHTGMJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HTGM + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HTGM pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HTGM
Annual income on $10K today (after 15% tax)
$35,416.67/yr
After 10yr DRIP, annual income (after tax)
$8,919,013,681.58/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, HTGM beats the other by $8,919,011,851.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HTGM + JEPQ for your $10,000?

HTGM: 50%JEPQ: 50%
100% JEPQ50/50100% HTGM
Portfolio after 10yr
$7723.45M
Annual income
$5,246,479,712.51/yr
Blended yield
67.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on HTGM right now

HTGM
Analyst Ratings
8
Buy
Consensus: Buy
Price Target
$0.17
-65.3% upside vs current
Range: $0.17 — $0.17
Altman Z
-35.3
Piotroski
3/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HTGM buys
0
JEPQ buys
0
No recent congressional trades found for HTGM or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHTGMJEPQ
Forward yield416.67%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$15446.85M$44.8K
Annual income after 10y$10,492,957,272.45$2,152.59
Total dividends collected$14996.03M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: HTGM vs JEPQ ($10,000, DRIP)

YearHTGM PortfolioHTGM Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$52,367$41,666.67$11,930$1,110.39+$40.4KHTGM
2$259,952$203,920.04$14,133$1,224.34+$245.8KHTGM
3$1,224,201$946,051.97$16,632$1,340.46+$1.21MHTGM
4$5,473,698$4,163,802.84$19,454$1,457.97+$5.45MHTGM
5$23,256,265$17,399,408.07$22,626$1,576.08+$23.23MHTGM
6$93,973,351$69,089,147.58$26,175$1,694.09+$93.95MHTGM
7$361,461,534$260,910,048.59$30,133$1,811.32+$361.43MHTGM
8$1,324,680,829$937,916,987.81$34,531$1,927.17+$1324.65MHTGM
9$4,629,809,751$3,212,401,263.77$39,403$2,041.08+$4629.77MHTGM
10$15,446,853,706$10,492,957,272.45$44,787$2,152.59+$15446.81MHTGM

HTGM vs JEPQ: Complete Analysis 2026

HTGMStock

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq DLBCL cell of origin assay; HTG EdgeSeq Oncology Biomarker Panel; HTG EdgeSeq ALKPlus assay EU; HTG EdgeSeq Pan B-Cell Lymphoma Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG Molecular Diagnostics, Inc. has a governing agreement with QIAGEN Manchester Limited. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

Full HTGM Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this HTGM vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HTGM vs SCHDHTGM vs JEPIHTGM vs OHTGM vs KOHTGM vs MAINHTGM vs XYLDHTGM vs QYLDHTGM vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.